Florida-based Ocenture LLC and Carelumina LLC, its subsidiary, have agreed to pay $3 million to resolve allegations that they caused false Medicare claims through kickbacks involving genetic testing samples, the Department of Justice said Thursday.
Ocenture allegedly paid physicians to falsely claims that genetic testing samples from Medicare beneficiaries were medically necessary so that a portion of the reimbursement could be paid to Ocenture, according to the DOJ.
This story was produced by Bloomberg Law Automation.
To read the full article log in.
Read Full Story: https://news.google.com/__i/rss/rd/articles/CBMie2h0dHBzOi8vbmV3cy5ibG9vbWJlc...
In the rainforest-covered province of Tshopo in northeastern Congo, fear began with whispers. Late last year, villagers circulated alarming stories that a mysterious illness was causing men’s geni...